10-Q/A XBRL

FORM 10-Q/A

Company: ATOSSA THERAPEUTICS, INC.
Filed: November 13, 2018
Period of Report: June 30, 2018
Accession Number: 0001615774-18-012549

View Document ↗ View on SEC.gov ↗